Invivyd, Inc.
NASDAQ:IVVDBiotechnology
Healthcare
$0.47 +4.16%
+$0.04 today
- Market cap
- $138.68M
- Beta
- 0.63
- P/E (TTM)
- -3.9
- EPS (TTM)
- -$0.25
52W Low $0.48High $3.07
Volume 6.71M
Average 3.62M
Income Statement
Follow revenue through to earnings.
Revenue
$53.43M
FY 2025 · Annual
+110.5% YoYOperating Income
-$55.56M
FY 2025 · Annual
Net Income
-$52.49M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 25.38M | 53.43M |
| Cost of Revenue | 0 | 0 | 0 | 1.62M | 3.75M |
| Gross Profit | 0 | 0 | 0 | 23.77M | 49.68M |
| Gross Margin | — | — | — | 93.6% | 93.0% |
| Research & Development | 182.89M | 179.21M | 158.66M | 137.25M | 38.31M |
| Selling, General & Admin | 36.52M | 47.04M | 49.13M | 63.39M | 66.93M |
| Operating Expenses | 226.91M | 248.03M | 212.76M | 200.64M | 105.24M |
| Depreciation & Amortization | 1K | 462K | 2.03M | 3.11M | 2.11M |
| EBITDA | (219.41M) | (225.8M) | (205.76M) | (166.81M) | (50.38M) |
| EBITDA Margin | — | — | — | -657.2% | -94.3% |
| Operating Income | (226.91M) | (248.03M) | (212.76M) | (176.88M) | (55.56M) |
| Operating Margin | — | — | — | -696.8% | -104.0% |
| Interest Income | 0 | 6.71M | 0 | 6.95M | 0 |
| Interest Expense | 0 | 43.08M | 0 | 0 | 0 |
| Other Income / Expenses | 118K | 6.71M | 14.12M | 6.95M | 3.07M |
| Income Before Tax | (226.79M) | (241.32M) | (198.64M) | (169.93M) | (52.49M) |
| Pre-Tax Margin | — | — | — | -669.4% | -98.2% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (226.79M) | (241.32M) | (198.64M) | (169.93M) | (52.49M) |
| Net Margin | — | — | — | -669.4% | -98.2% |
| EPS (Basic) | (2.11) | (2.17) | (1.81) | (1.43) | (0.30) |
| EPS (Diluted) | (2.11) | (2.17) | (1.81) | (1.43) | (0.30) |
| 110.78M | 108.27M | 109.53M | 118.56M | 172.21M | |
| 110.78M | 108.27M | 109.53M | 118.56M | 172.21M |
IVVD Earnings Waterfall · TTM
NASDAQ:IVVD · Revenue to Net Income
Key Ratios
EPS$-0.37
Gross Margin92.0%
Net Margin-142.4%
P/E Ratio-4.5
P/S Ratio18.9
Analysis
$55.9M of revenue converted into -$77.6M of net income for the selected period. Gross margin is 92.0% and net margin is -142.4%, showing how much revenue survives after costs and taxes. EPS is $-0.37, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Sep 29, 2026 | |
| 3 | Initial statement of beneficial ownership | Sep 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 1, 2026 | |
| 8-K | Current report | Sep 1, 2026 |
How much revenue does IVVD generate?
Invivyd, Inc. (IVVD) reported $53.43M of revenue in fiscal 2025.
Is IVVD profitable?
Invivyd, Inc. (IVVD) reported -$52.49M of net income, with a net margin of -98.2%.
Continue the stock analysis
Jump to another research area for this company.